TITLE

Attitudes Toward Prenatal Genetic Testing in Patients With Familial Adenomatous Polyposis

AUTHOR(S)
Kastrinos, Fay; Stoffel, Elena M.; Balmaña, Judith; Syngal, Sapna
PUB. DATE
June 2007
SOURCE
American Journal of Gastroenterology;Jun2007, Vol. 102 Issue 6, p1284
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES: Familial adenomatous polyposis (FAP) is an autosomal dominant syndrome with >95% risk of colorectal cancer without prophylactic colectomy. Classic FAP is commonly associated with adenomatous polyposis coli ( APC) gene mutations. If a mutation is identified, prenatal testing can reveal whether an embryo or fetus is affected. We conducted a pilot study to assess FAP patients' attitudes toward prenatal testing. METHODS: Twenty individuals with FAP completed a 40-item survey on personal and family history related to FAP, demographics, and attitudes toward prenatal tests including amniocentesis, chorionic villous sampling (CVS), and preimplantation genetic diagnosis (PGD). RESULTS: Thirteen women and seven men participated. Ninety-five percent (19/20) would consider undergoing prenatal testing for FAP: 90% would consider PGD, 75% would consider amniocentesis or CVS. Having an affected child and experiencing a first-degree relative's (FDR) death secondary to FAP were associated with greater willingness to consider prenatal testing. Personal history of cancer or FAP-associated tumors did not influence the decision to consider prenatal testing. One hundred percent said it was ethical to provide prenatal testing for FAP and four of five subjects who self-reported strong religious backgrounds would consider prenatal testing for FAP. Early reassurance of having an unaffected child was the most important advantage of PGD and avoiding pregnancy termination was important for 64% and 71% of women and men, respectively. CONCLUSIONS: Patients with FAP are willing to consider prenatal testing to prevent transmission of disease to their children. Physicians caring for FAP patients should discuss available prenatal diagnostic options with patients of childbearing age.
ACCESSION #
25137402

 

Related Articles

  • HNPCC Bethesda Guidelines revised.  // Patient Care;Apr2004, Vol. 38 Issue 4, p7 

    Reports on the revision of the Bethesda Guidelines criteria for testing for hereditary nonpolyposis colorectal cancer (HNPCC), as of April 2004. Information on a major genetic characteristic of HNPCC tumors; Types of patients that should be recommended for subsequent genetic testing.

  • Efficacy of the Health Belief Model for Predicting Intention to Pursue Genetic Testing for Colorectal Cancer. Cyr, Amanda; Dunnagan, Tim; Haynes, George // Journal of Genetic Counseling;Apr2010, Vol. 19 Issue 2, p174 

    This study examined the Health Belief Model’s efficacy to predict intention to undergo genetic testing for the Colorectal Carcinoma (CRC) gene within a rural/frontier setting. Survey data were collected on 558 Southwest Montanan residents. Regression analysis revealed that perceived...

  • PGS does not Benefit Live Birth Rate among Older Women with Aneuploidy Risk.  // Fertility Weekly;3/2/2009, p7 

    The article reports on a study in the Netherlands in determining whether the effect of preimplantation genetic screening (PGS) on live births varies in women of advanced maternal age with variable risk for embryonic aneuploidy. It reveals that PGS does not benefit live birth rate among older...

  • Clinical Diagnosis by Whole-Genome Sequencing of a Prenatal Sample. Talkowski, Michael E.; Ordulu, Zehra; Pillalamarri, Vamsee; Benson, Carol B.; Blumenthal, Ian; Connolly, Susan; Hanscom, Carrie; Hussain, Naveed; Pereira, Shahrin; Picker, Jonathan; Rosenfeld, Jill A.; Shaffer, Lisa G.; Wilkins-Haug, Louise E.; Gusella, James F.; Morton, Cynthia C. // New England Journal of Medicine;12/6/2012, Vol. 367 Issue 23, p2226 

    : Conventional cytogenetic testing offers low-resolution detection of balanced karyotypic abnormalities but cannot provide the precise, gene-level knowledge required to predict outcomes. The use of high-resolution whole-genome deep sequencing is currently impractical for the purpose of routine...

  • New Standards for Gene Synthesis Screening. KAEBNICK, GREGORY E. // Hastings Center Report;Jan2010, Vol. 40 Issue 1, p49 

    The article discusses the code of conduct for gene synthesis screening. The new standards is being negotiated by the International Association for Synthetic Biology, a trade group. Their proposal requires human screeners which the author considers as expensive. An alternative proposal will rely...

  • Population Screening in the Age of Genomic Medicine. Khoury, Muin J.; McCabe, Linda L.; McCabe, Edward R.B. // New England Journal of Medicine;1/2/2003, Vol. 348 Issue 1, p50 

    Speculates about the future of genetic population screening. Probability that physicians will screen populations or specific subgroups for genetic information in order to target interventions to individual patients that will improve their health and prevent disease; Use of genetic information to...

  • Is genetic screening for the Lynch syndrome effective? Misak, Aleksandra // CMAJ: Canadian Medical Association Journal;6/7/2005, Vol. 172 Issue 12, p1557 

    Discusses research being done on the effectiveness of genetic screening for the Lynch syndrome. Reference to a study by H. Hampel et al, published in the 2005 issue of the "New England Journal of Medicine"; Background of the research; Results; Practice implications.

  • Moving toward a World with Fewer Children with Down Syndrome. ANDRUSKO, DAVE // National Right to Life News;Mar2009, Vol. 36 Issue 3, p11 

    The article comments on an article by Rob Stein on the current state of efforts to develop a noninvasive genetic test for Down syndrome. A 2007 recommendation by the American College of Obstetricians and Gynecologists that all women be offered screening tests for Down syndrome is cited as the...

  • New Tests Could Divine a Baby's Genome Before Birth. Humphries, Courtney // MIT Technology Review;Nov/Dec2012, Vol. 115 Issue 6, p18 

    The article discusses the development of blood tests for noninvasive prenatal medical screening to identify potential health problems in unborn babies. Topics include studies on decoding the fetal genome from a sample of the mother's blood; research for the treatment of genetic diseases; and the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics